ORAI3 and breast carcinoma: Whilst far less studied than its sibling Orai1, Orai3 protein deserves special attention, because of (i) its exclusive presence in mammals [37], (ii) its receptivity to pharmacological modulation [38], and (iii) its recent emergence in the cancer field, especially in breast cancer.